Morgan Stanley still prefers Moody's Corporation (NYSE: MCO) over S&P Global Inc (NYSE: SPGI) on valuation and said the credit environment proving calmer than many
anticipate three weeks post-Brexit.
Moody's reported higher mix of ratings profits and transactional revenue vs. S&P Global; however, Moody's shares initially
fell more (14 percent vs.10 percent), although both have since rebounded beyond pre-Brexit levels.
"[W]e still prefer Moody's based on current valuation and the potential for upside from upcoming IG and HY debt maturities,"
analyst Toni Kaplan wrote in a note.
Kaplan, who has an Overweight rating on Moody's, expects earnings beats from both names, as the second-quarter issuance is
mixed, but better than the more negative outlook that was seen after the first quarter.
Related Link: Argus
Analysts Bullish On Stocks For 2016's Second Half
"Corporate issuance was flowing flat to slightly positive in 2Q, which is a notable improvement for high yield after four
consecutive quarters of double-digit revenue declines. Structured issuance continued to be weak, however, driven by soft CMBS, CLOs
and CDOs," Kaplan noted.
Kaplan raised the second-quarter EPS view of Moody's by $0.03 to $1.32 and S&P by $0.02 to $1.40. For FY16, Kaplan
maintained his EPS estimate of Moody's at $4.62, while raising S&P EPS estimate by $0.09 to $5.18, primarily on forex. The
analyst remains Equal Weight on S&P.
"We estimate that the weakening of the GBP and Euro this quarter will be a ~$0.09 tailwind to SPGI and a ~$0.07 tailwind to MCO
NTM. Both firms should benefit from having large cost bases in the U.K. with the weakening GBP, but this will be somewhat mitigated
by the revenue impact from a softer Euro," Kaplan added.
Kaplan raised the price target of S&P by $5 to $120, while maintaining Moody's target price at $114.
At time of writing, shares of Moody's were up 0.43 percent to $103.78 and S&P were up 0.69 percent to $116.44.
Did you like this article? Could it have been improved? Please email feedback@benzinga.com with the story link to let us know!
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.